COMI, Cristoforo
 Distribuzione geografica
Continente #
EU - Europa 9.742
NA - Nord America 8.660
AS - Asia 5.405
SA - Sud America 950
Continente sconosciuto - Info sul continente non disponibili 327
AF - Africa 194
OC - Oceania 3
Totale 25.281
Nazione #
US - Stati Uniti d'America 8.382
RU - Federazione Russa 2.231
NL - Olanda 1.914
SG - Singapore 1.879
IE - Irlanda 1.492
CN - Cina 1.238
IT - Italia 959
DE - Germania 864
VN - Vietnam 741
BR - Brasile 712
HK - Hong Kong 712
SE - Svezia 624
UA - Ucraina 495
FR - Francia 355
FI - Finlandia 304
GB - Regno Unito 194
IN - India 192
CA - Canada 160
BD - Bangladesh 154
KR - Corea 95
AR - Argentina 92
ID - Indonesia 80
BJ - Benin 78
JP - Giappone 65
PL - Polonia 64
MX - Messico 62
EC - Ecuador 47
ZA - Sudafrica 44
CZ - Repubblica Ceca 43
AT - Austria 38
ES - Italia 37
TR - Turchia 33
IR - Iran 30
CO - Colombia 29
IQ - Iraq 29
BE - Belgio 28
LT - Lituania 23
GR - Grecia 21
PY - Paraguay 21
MA - Marocco 17
SA - Arabia Saudita 17
PH - Filippine 15
PK - Pakistan 14
VE - Venezuela 14
CL - Cile 13
IL - Israele 13
UZ - Uzbekistan 13
EG - Egitto 12
PE - Perù 12
CR - Costa Rica 11
DZ - Algeria 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
EU - Europa 9
RO - Romania 9
AZ - Azerbaigian 8
KE - Kenya 8
NP - Nepal 8
TN - Tunisia 8
KZ - Kazakistan 7
MY - Malesia 7
TW - Taiwan 7
UY - Uruguay 7
CH - Svizzera 6
HN - Honduras 6
LB - Libano 6
AL - Albania 5
EE - Estonia 5
JO - Giordania 5
KW - Kuwait 5
LV - Lettonia 5
MD - Moldavia 5
SN - Senegal 5
TH - Thailandia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
PA - Panama 4
TT - Trinidad e Tobago 4
AU - Australia 3
BS - Bahamas 3
BY - Bielorussia 3
DK - Danimarca 3
NI - Nicaragua 3
OM - Oman 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
LK - Sri Lanka 2
MK - Macedonia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
Totale 24.945
Città #
Amsterdam 1.891
Dublin 1.490
San Jose 1.140
Jacksonville 861
Hong Kong 705
Singapore 658
Council Bluffs 587
Ashburn 511
Dearborn 431
Beijing 341
Moscow 282
Los Angeles 262
Ho Chi Minh City 235
Columbus 220
Chandler 213
Lauterbourg 213
Wilmington 200
Lawrence 179
Princeton 179
New York 139
Hanoi 138
Phoenix 130
Santa Clara 124
Milan 114
Buffalo 113
San Mateo 110
Ann Arbor 98
Dallas 98
Munich 96
Piemonte 89
Seoul 86
São Paulo 79
Cotonou 78
Novara 74
Andover 72
Helsinki 72
Orem 70
Boardman 68
Turin 68
Rome 56
Dong Ket 52
Denver 48
Houston 47
Toronto 47
Warsaw 47
Chicago 46
Bremen 45
Tokyo 45
Chennai 44
Brooklyn 43
Falkenstein 39
Brno 38
Frankfurt am Main 37
Nuremberg 37
Redondo Beach 37
Jakarta 36
Montreal 35
Da Nang 34
Monmouth Junction 34
Woodbridge 34
Guangzhou 33
Atlanta 32
Hefei 31
Johannesburg 31
Hangzhou 30
London 30
St Louis 30
Tianjin 30
Boston 29
Grafing 29
Manchester 27
Poplar 27
Seattle 27
Turku 27
Brussels 26
Mumbai 26
Stockholm 26
Torino 26
Mexico City 25
Strasbourg 25
Haiphong 24
Nanjing 24
Düsseldorf 22
Guayaquil 21
Belo Horizonte 19
Rio de Janeiro 19
Vienna 19
Mülheim 18
Philadelphia 18
Shanghai 18
Ankara 17
Brasília 17
Norwalk 17
Vercelli 17
Charlotte 16
Dhaka 16
Fairfield 15
Hải Dương 15
Kunming 15
San Francisco 15
Totale 14.324
Nome #
Post-lumbar puncture headache: an adverse effect in multiple sclerosis work-up 1.922
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 269
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 211
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 186
Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study 185
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report 181
Change over time of COVID-19 hospital presentation in Northern Italy 173
Anti-cytokine autoantibodies in autoimmune diseases 169
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 164
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 161
Circulating extracellular vesicles in subarachnoid hemorrhage patients: characterization and cellular effects 157
Impaired visual inhibition in migraine with aura. 154
Cortical visuomotor interactions in Freezing of Gait: A TMS approach 154
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 153
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 153
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 149
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 145
Insights into the protective role of immunity in neurodegenerative disease 145
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis 145
Kappa free light chains could predict early disease course in multiple sclerosis 142
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 141
Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis 138
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 138
Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs 138
A91V variation of the perforin gene in patients with multiple sclerosis 137
Calcium and glutamate involvement in activation of multiple sclerosis patient lymphocytes 136
K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up 136
A patient with autoimmune limb-girdle myasthenia, and a brief review of this treatable condition 135
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 135
Phenotypic heterogeneity of movement disorders due to intracranial calcifications with or without SLC20A2 mutations 135
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 134
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 134
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 133
Polymorphisms of dopamine receptor genes and parkinson’s disease: Clinical relevance and future perspectives 133
Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients 132
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases 131
An investigation of the role of common and rare variants in a large italian multiplex family of multiple sclerosis patients 130
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population 130
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 128
Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis 127
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 126
A case of progressive multifocal leukoencephalopathy after autologous bone marrow transplantation successfully treated with mirtazapine and cidofovir 126
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 125
Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence 125
Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients 125
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 124
Advances in Neuroimmunology: From Bench to Bedside 122
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies 122
Short-term videoEEG: Review of a 3-year experience [Short-term videoEEG: Studio retrospettivo di 3 anni di esperienza clinica] 121
ICOS gene haplotypes correlate with multiple sclerosis development and progression 119
MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis 119
Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know? 118
Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis 117
Complex pattern of convulsive syncope in glossopharyngeal neuralgia: video/EEG report and short review 117
The Yin-Yang of osteopontin in nervous system diseases: Damage versus repair 117
Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis 116
Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP 116
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 116
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 116
Intrathecal kappa free light chains as markers for multiple sclerosis 115
Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy 114
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 113
Erratum: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (Cell (2019) 178(1) (262), (S0092867419306798), (10.1016/j.cell.2019.06.016)) 112
A novel genetic prediction score in myoclonus-dystonia 111
IV lacosamide: Report of two cases of successful treatment of refractory status epilepticus [Utilizzo di lacosamide ev: Esperienza in due casi di stato di male epilettico refrattario] 111
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis 111
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 110
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 109
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk 109
Serum vitamin d as a marker of impaired information processing speed and early disability in multiple sclerosis patients 109
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 108
Osteopontin is increased in the cerebrospinal fluid of patients with early Alzheimer's disease and its levels correlate with cognitive deterioration 108
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 107
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 107
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 107
CD4+ T-Cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson’s Disease 107
Paraneoplastic neuromyelitis optica spectrum disorders: a case series 107
Variations of the perforin gene in patients with multiple sclerosis 106
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 105
Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: A retrospective case-control study 104
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 104
A very early onset of juvenile parkinsonism 103
CGRP beyond migraine: exploring its serum and CSF levels in multiple sclerosis. 103
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline 103
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 103
Anticonvulsant Drugs and Cognitive Functions in Elderly Patients with Epilepsy 102
Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis 102
Intensive Rehabilitation Treatment in Early Parkinson's Disease: A Randomized Pilot Study With a 2-Year Follow-up 102
Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson's Disease: A Single-Center Longitudinal Study 101
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 101
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 101
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 101
T Lymphocytes in Parkinson's Disease 101
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 100
LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients 100
A Novel GBF1 Variant in a Charcot-Marie-Tooth Type 2: Insights from Familial Analysis 99
Immunity and inflammation in neurodegenerative diseases. 99
Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis 99
Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature 99
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 98
Totale 14.397
Categoria #
all - tutte 122.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022997 0 0 0 137 57 18 127 22 120 47 176 293
2022/20232.596 204 138 135 27 118 183 85 101 1.439 18 98 50
2023/20241.201 77 52 114 48 202 23 210 70 27 13 108 257
2024/20252.939 65 47 200 96 63 217 288 213 740 207 249 554
2025/202611.859 438 338 675 1.475 981 653 1.521 1.667 2.459 776 606 270
2026/20272.030 417 787 710 116 0 0 0 0 0 0 0 0
Totale 25.281